Delivery Order SPE2DB22D1106-SPE2DB24FDQZ2
Award Date
12/15/23
Potential Completion Date
12/18/23
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $2,061.76 from the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply 30 tablets of 3mg doxepin hydrochloride. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 9, 2023. No set-aside designation was applied. As a prime contractor supporting DLA Troop Support Medical...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Doxepin Hydrochloride 3 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The firm-fixed-price delivery order, valued at $1,815.47, has an ultimate completion date of December 6, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation mentioned. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,383.69 Firm Fixed Price Delivery Order (Contract #SPE2DB22D1017|SPE2DB24FF7GQ) is for the supply of 4,564,529,766 units of Doxepin HCL 3 mg tablets, with a performance period through May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,797.01, is a Firm Fixed Price Delivery Order to provide 4566692078 - DOXEPIN HCL 3 MG TABLET 30S. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Doxepin HCL 3 mg tablets to the Defense Logistics Agency (DLA). The $2,252.89 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies for military healthcare programs globally. The contract has...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $2,208.88, is for the delivery of doxepin hydrochloride 3 milligram tablets. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FFBB3, is a Delivery Order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp's Corporate Office Division. The $8,965.24 firm fixed-price contract is for the supply of 4,565,098,844 units of the pharmaceutical product Doxepin HCL 3 mg Tablets. The contract has an ultimate completion date of July 10, 2024 and was awarded on July 9, 2024. It is not associated with any set-aside designation. Amerisourcebergen Drug...
This federal contract award, SPE2DB20D1051|SPE2DB24FD6KS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,430.68 firm fixed-price delivery order is for 4,563,172,295 units of the medication Doxepin HCL 3 mg tablets. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023. There was no set-aside designation for this contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution services company. The contract is for the delivery of 4564074174 - Doxepin HCL 3 MG Tablet 30S, a pharmaceutical product, with a ceiling value of $1,494.70 and a period of performance through March 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
Defense Logistics Agency awarded a delivery order against an unspecified contract vehicle to Amerisourcebergen Drug Corp on October 17, 2023. The order, valued at one thousand six dollars and sixteen cents ($1,006.16), is for one hundred (100) capsules of the pharmaceutical product doxepin hydrochloride at 50 milligrams per capsule. Place of performance will be the awardee's facility located in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen...